|
| Study ID | Membrane | Patients ()/implants () | No. of patients (mean age; range of age) (in years) | Bone graft materials | Follow-up time (months) | Vertical bone gain (mm/%) | GBR/GTR |
|
| Ronda et al. [33] | Titanium-reinforced, d-PTFE | 12/38 | 23 (49.60/30–78) | Autologous bone and mineralized bone allograft (1 : 1) | 6 | | GBR |
Titanium-reinforced
e-PTFE | 11/40 | |
| Pruthi et al. [13] | e-PTFE | 17/17 | 17 (56.50/35–75) | NA | 12 | | GTR |
| CM | 17/17 | |
| Moses et al. [15] | CM | 28/53 | 28 (50.50/NA) | Autogenous bone chips mixed with either bovine bone mineral | 6–8 | | GBR |
| e-PTFE | 17/34 | 17 (55.40/NA) | |
| Annen et al. [11] | CCM | 9/9 | 9 (50.20/NA) | Bovine bone mineral granules | 6 | | GBR |
| CM | 9/9 | |
| Carpio et al. [16] | CM | 23/23 | 48 (NA/NA) | Anorganic bovine bone plus; autogenous bone chips (1 : 1) | 6 | | GBR |
| e-PTFE | 25/25 | |
| Lee et al. [22] | CM | 14/14 | 28 (53.30/31–75) | Xenograft bone substitutes | 4 | | GBR |
| CCM | 14/14 | |
| Scheyer et al. [35] | CM | 19/19 | 40 (NA/18–70) | Demineralized allograft | 6 | | GBR |
| CCM | 21/21 | Deproteinized bovine bone mineral | |
| Arbab et al. [45] | CM | 12/12 | 12 (53.00/25–73) | Cancellous allograft and bovine-derived xenograft | 4 | | GBR |
| d-PTFE | 12/12 | 12 (52.00/30–73) | |
| Naenni et al. [27] | CM | 13/13 | 27 (51.85/NA) | Demineralized bovine bone mineral | 6 | | GBR |
| Titanium-reinforced; e-PTFE | 14/14 | |
| Cucchi et al. [46] | d-PTFE | 19/54 | 36 (52.00/NA) | Autogenous bone and bone allograft (1 : 1) | 12 | | GBR |
| TM + CCM | 17/44 | |
| Lim et al. [23] | CCM | 12/12 | 12 (53.83/NA) | Collagenated porcine bone | 4 | | GBR |
| CM | 14/14 | 14 (48.14/NA) | Collagenated bovine bone | |
| Maiorana et al. [34] | Titanium-reinforced; d-PTFE | 5/5 | 5 (54.20/38–65) | Autogenous bone and deproteinized bovine bone mineral particles (1 : 1) | 8 | | GBR |
| TM | 5/5 | |
| Teparat et al. [19] | e-PTFE | 10/9 | 10 (NA/40–65) | NA | 9 | | GBR |
| PLA | 10/10 | |
| Blumenthal [17] | e-PTFE | 12/12 | 12 (NA/31–80) | NA | 12 | | GBR |
| CM | 12/12 | |
| Christgau et al. [47] | PLA 910 | NA/16 | 11 (40.40/23–59) | NA | 12 | | GTR |
| e-PTFE | NA/14 | |
| Merli et al. [28] | CM | 11/42 | 11 (44.60/29–59) | Autologous bone | 72 | | GBR |
| Titanium-reinforced; e-PTFE | 10/55 | 10 (49.90/36–69) | |
| Kim et al. [48] | PLA 910 | 8/8 | 8 (NA/NA) | NA | 6 | | GTR |
| e-PTFE | 8/8 | |
| Karapataki et al. [20] | PLA | 10/10 | 19 (43.00/NA) | NA | 12 | | GTR |
| e-PTFE | 9/9 | |
| Choi et al. [32] | TM | 15/17 | 100 (57.10/20–82) | An allograft bone | 6 | | GBR |
| TM + CCM | 56/72 | |
| TM + CM | 29/40 | |
| Friedmann et al. [26] | CCM | 17/37 | 37 (NA/24–69) | A coagulum was formed by the calcium phosphate grafting material | 6 | / | GBR |
| CM | 20/36 |
| Tal et al. [24] | CCM | 52/52 | 52 (46.00/20–70) | Deproteinized bovine bone mineral | 6 | GBR |
| CM | 52/52 |
| Weltman et al. [21] | PLA | 30/16 | 30 (NA/26–64) | NA | 12 | GBR |
| e-PTFE | 30/14 |
| Atef et al. [49] | CM | 20/10 | 20 (NA/20–60) | Autogenous and anorganic bovine bone mineral bone mixture (1 : 1) | 6 | GBR |
| TM | 20/10 |
| Jung et al. [30] | PEG | 57/57 | 117 (48.70/19–77) | A synthetic bone filler | 6 | GBR |
| BG | 57/57 |
| Jung et al. [31] | PEG | 19/19 | 19 (48.00/32–72) | A natural bone mineral of bovine origin | 6 | GBR |
| CM | 18/18 | 18 (54.00/23–80) |
| Cucchi et al. [14] | TM | 15/34 | 30 (NA/NA) | Autogenous bone and bone xenograft (1 : 1) | 6 | GBR |
| TM + CCM | 15/37 |
| Becker et al. [25] | CCM | 23/41 | 23 (44.90/NA) | Natural bone mineral | 4 | GBR |
| CM | 26/37 | 26 (42.40/NA) |
|
